Skip to Primary Navigation

Skip to main content

Founder, clinical president of telehealth company convicted in $100m Adderall fraud scheme

Open prescription drug bottle with pills and capsules spilled out on table
Photo: Spencer Platt/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The case demonstrates the first federal prosecution of alleged illegal drug distribution by a telehealth entity.

The US Department of Justice (DOJ) announced the founder and a former chief clinician at Done Global were convicted in a San Francisco court of conspiring to distribute Adderall and other stimulants.

CEO Ruthia He, who founded the telehealth company, and former Clinical President David Brody were each found guilty

, , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience